Flora Growth Appoints Industry-Leading Cultivator Derek Pedro as Genetics and Cultivation Advisor
Flora Growth Corp. (NASDAQ: FLGC) appointed Derek Pedro, a renowned cannabis genetics and cultivation expert, as an advisor to its Cosechemos cultivation facility. With over 30 years of experience and a track record of developing successful cannabis strains, Pedro will enhance Flora's high-THC and high-CBD offerings for domestic and international markets. This appointment coincides with Flora's expansion efforts and the recent completion of its EU-GMP compliant extraction lab, aiming to optimize operations in Colombia's favorable cultivation environment.
- Appointment of Derek Pedro as advisor to enhance cannabis genetics and cultivation.
- Pedro's extensive experience and reputation may strengthen market offerings.
- Completion of EU-GMP compliant extraction lab supports production capabilities.
- None.
The establishment of the genetics and cultivation advisor role comes as Flora ramps up cannabis production, including its recently completed EU-GMP compliant extraction lab. The appointment of
“As an internationally recognized industry expert and innovative cultivator, the appointment of
“The Flora team has become a leader in the cannabis sector since their successful IPO in 2021 and continues to focus on growth and world class production into 2022,” Pedro said. “I am excited to join this talented team, contributing to the management of Cosechemos’ large-scale grow in
Prior Press Release Correction
In a press release issued on
About
Flora is building a connected, design-led collective, of plant-based wellness and lifestyle brands, that delivers the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. Visit www.floragrowth.ca or follow @floragrowthcorp on social for more information.
Cautionary Statement Concerning Forward-Looking Statements
This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: the size of markets for cannabis and cannabis products; Flora’s ability to execute on its research and pharmaceutical strategies; the results of Flora’s research; the collaboration with third parties; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking events discussed in this document and other statements made from time to time by us or our representatives not occurring, except as may be required by applicable law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220124005240/en/
Investor Relations Contact:
evan.veryard@floragrowth.ca
Public Relations Contact:
+1 (858) 264-6600
flora@cmwmedia.com
Source:
FAQ
Who is Derek Pedro and what is his role at Flora Growth Corp.?
How will Derek Pedro impact Flora Growth Corp.?
What is the significance of the EU-GMP compliant extraction lab?